OOCUITY Trademark

Trademark Overview


On Monday, May 12, 2025, a trademark application was filed for OOCUITY with the United States Patent and Trademark Office. The USPTO has given the OOCUITY trademark a serial number of 99180527. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Monday, January 5, 2026. This trademark is owned by Nanobiotix. The OOCUITY trademark is filed in the Pharmaceutical Products, Medical Instrument Products, and Computer & Software Services & Scientific Services categories with the following description:

Scientific and technological services, namely, research and design services, in the field of nanomedicine, namely, nanotechnology applied to medicine; Biological research; Design and development of new products for third parties; Chemical analysis; Research in the field of chemistry; Neuroscience research; Radiobiology research

Pharmaceutical products for medical use for the treatment of psychiatric diseases and disorders; Pharmaceutical preparation for the diagnosis and treatment of brain diseases and disorders; Pharmaceutical preparation for medical use for the treatment of Parkinson's disease, Alzheimer's disease, epilepsy and all types of neurological and neuropsychiatric disorders and diseases; Pharmaceutical preparation for medical use for the treatment of symptoms of Parkinson's disease, symptoms of Alzheimer's disease, symptoms of epilepsy and symptoms linked to all types of neurological and neuropsychiatric disorders and diseases; Pharmaceutical preparation for the diagnosis and treatment of neurological disorders and diseases for use with deep brain stimulation, transcranial electrical stimulation, transcranial direct current stimulation, transcranial magnetic stimulation, any form of electromagnetic stimulation including light, magnetic field, electric field, radio frequency or ultrasound stimulati...

Surgical devices and instruments, in particular for the diagnosis and treatment of tumors; Surgical apparatus and instruments, in particular for the diagnosis and treatment of cerebral diseases and disorders; Surgical devices and instruments for use with deep brain stimulation, transcranial electrical stimulation, transcranial direct current stimulation, transcranial magnetic stimulation, any form of electromagnetic stimulation including light, magnetic field, electric field, radiofrequency or ultrasound stimulation; Drug delivery agents in the form of dissolvable films that facilitate the delivery of therapeutic and diagnostic agents; medical microsyringes that facilitate the delivery of therapeutic and diagnostic agents; Medical device for recording cerebral electrical activity, namely, electrodes, electroencephalograph, microelectrode arrays
oocuity

General Information


Serial Number99180527
Word MarkOOCUITY
Filing DateMonday, May 12, 2025
Status653 - SUSPENSION LETTER - MAILED
Status DateMonday, January 5, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesScientific and technological services, namely, research and design services, in the field of nanomedicine, namely, nanotechnology applied to medicine; Biological research; Design and development of new products for third parties; Chemical analysis; Research in the field of chemistry; Neuroscience research; Radiobiology research
Goods and ServicesPharmaceutical products for medical use for the treatment of psychiatric diseases and disorders; Pharmaceutical preparation for the diagnosis and treatment of brain diseases and disorders; Pharmaceutical preparation for medical use for the treatment of Parkinson's disease, Alzheimer's disease, epilepsy and all types of neurological and neuropsychiatric disorders and diseases; Pharmaceutical preparation for medical use for the treatment of symptoms of Parkinson's disease, symptoms of Alzheimer's disease, symptoms of epilepsy and symptoms linked to all types of neurological and neuropsychiatric disorders and diseases; Pharmaceutical preparation for the diagnosis and treatment of neurological disorders and diseases for use with deep brain stimulation, transcranial electrical stimulation, transcranial direct current stimulation, transcranial magnetic stimulation, any form of electromagnetic stimulation including light, magnetic field, electric field, radio frequency or ultrasound stimulation; Nanoparticles for medical use, namely, nanomaterial-based chemical preparations for medical and pharmaceutical purpose for the treatment of central nervous system disorder; Chemical reagents for medical use; Chemical preparations for medical or pharmaceutical use , namely, for the treatment of central nervous system disorders; Diagnostic preparations for medical purposes; Medicines for human medicine, namely, medical preparations for the treatment of central nervous system disorders; Pharmaceutical products for the treatment of central nervous system disorders
Goods and ServicesSurgical devices and instruments, in particular for the diagnosis and treatment of tumors; Surgical apparatus and instruments, in particular for the diagnosis and treatment of cerebral diseases and disorders; Surgical devices and instruments for use with deep brain stimulation, transcranial electrical stimulation, transcranial direct current stimulation, transcranial magnetic stimulation, any form of electromagnetic stimulation including light, magnetic field, electric field, radiofrequency or ultrasound stimulation; Drug delivery agents in the form of dissolvable films that facilitate the delivery of therapeutic and diagnostic agents; medical microsyringes that facilitate the delivery of therapeutic and diagnostic agents; Medical device for recording cerebral electrical activity, namely, electrodes, electroencephalograph, microelectrode arrays

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, May 12, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, May 12, 2025
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, May 12, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNanobiotix
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParis 75012
FR

Trademark Events


Event DateEvent Description
Monday, May 12, 2025NEW APPLICATION ENTERED
Monday, May 12, 2025APPLICATION FILING RECEIPT MAILED
Sunday, September 21, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 25, 2025ASSIGNED TO EXAMINER
Friday, September 26, 2025NON-FINAL ACTION WRITTEN
Friday, September 26, 2025NON-FINAL ACTION E-MAILED
Friday, September 26, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, December 21, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, December 21, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, December 21, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 5, 2026EXAMINERS AMENDMENT -WRITTEN
Monday, January 5, 2026EXAMINERS AMENDMENT E-MAILED
Monday, January 5, 2026NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, January 5, 2026EXAMINER'S AMENDMENT ENTERED
Monday, January 5, 2026SUSPENSION LETTER WRITTEN
Monday, January 5, 2026LETTER OF SUSPENSION E-MAILED
Monday, January 5, 2026NOTIFICATION OF LETTER OF SUSPENSION E-MAILED